Cannabix Technologies (Cannabix Technologies) Cash-to-Debt : 113.36 (As of Jan. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Cannabix Technologies Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Cannabix Technologies's cash to debt ratio for the quarter that ended in Jan. 2024 was 113.36.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Cannabix Technologies could pay off its debt using the cash in hand for the quarter that ended in Jan. 2024.

The historical rank and industry rank for Cannabix Technologies's Cash-to-Debt or its related term are showing as below:

BLOZF' s Cash-to-Debt Range Over the Past 10 Years
Min: 48.65 Med: No Debt Max: No Debt
Current: 114.14

During the past 12 years, Cannabix Technologies's highest Cash to Debt Ratio was No Debt. The lowest was 48.65. And the median was No Debt.

BLOZF's Cash-to-Debt is ranked better than
89.19% of 860 companies
in the Medical Devices & Instruments industry
Industry Median: 2.03 vs BLOZF: 114.14

Cannabix Technologies Cash-to-Debt Historical Data

The historical data trend for Cannabix Technologies's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Cannabix Technologies Cash-to-Debt Chart

Cannabix Technologies Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

48.47

Cannabix Technologies Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Cash-to-Debt	Get a 7-Day Free Trial															No Debt	48.47	56.59	73.35	113.36

Competitive Comparison of Cannabix Technologies's Cash-to-Debt

For the Medical Devices subindustry, Cannabix Technologies's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabix Technologies's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cannabix Technologies's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Cannabix Technologies's Cash-to-Debt falls into.

Cannabix Technologies Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Cannabix Technologies's Cash to Debt Ratio for the fiscal year that ended in Apr. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	4.798	/	(0.09	+	0.009)
	=	48.46

Cannabix Technologies's Cash to Debt Ratio for the quarter that ended in Jan. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	3.741	/	(0.033	+	0)
	=	113.36

Cannabix Technologies (OTCPK:BLOZF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Cannabix Technologies Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Cannabix Technologies's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabix Technologies (Cannabix Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cannabix Technologies Inc (OTCPK:BLOZF) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

8CT:Germany BLO:Canada

Address

501-3292 Production Way, Burnaby, BC, CAN, V5A 4R4

Website

https://www.cannabixtechnologies.com

Cannabix Technologies Inc is in the development of marijuana breathalyzer. It is developing breath testing technologies that can be used at the point of care to detect recent use of marijuana. It is also developing its technology to help employers, law enforcement, government and the public, when marijuana is becoming legal for recreational and medicinal use in many jurisdictions globally. The FAIMS device is designed to operate both independently or coupled in tandem directly to a mass spectrometer, used in forensic labs. The THC Breath Analyzer is a point of care breath testing tool for the rapid detection of recent cannabis use.

Cannabix Technologies (Cannabix Technologies) Headlines

From GuruFocus

New Canadian Study Shows Widespread Drugged Driving -- CFN Media

By Marketwired Marketwired • 08-14-2018

Cannabix Technologies Provides Update on THC Breath Analyzer Development and Testing

By Marketwired Marketwired • 08-13-2020

Recent Vermont Legislation Highlights Hurdles Surrounding Cannabis Impairment Testing -- CFN Media

By Marketwired Marketwired • 06-05-2018

US and Canadian Officials Scramble to Solve Marijuana-Impaired Driving Issue -- CFN Media

By Marketwired Marketwired • 04-17-2018

Cannabis Users Drive High, and Crashes Are on the Rise-- CFN Media

By Marketwired Marketwired • 12-15-2018